共 42 条
- [31] Evaluation of In Vitro Activity of Double-Carbapenem Combinations against KPC-2-, OXA-48-and NDM-Producing Escherichia coli and Klebsiella pneumoniae ANTIBIOTICS-BASEL, 2022, 11 (11):
- [34] Geographical patterns of in vitro susceptibilities to tigecycline and colistin among worldwide isolates of Acinetobacter baumannii, Escherichia coli and Klebsiella pneumoniae: Data from the Antimicrobial Testing Leadership and Surveillance (ATLAS) programme, 2016-2021 INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2023, 62 (03)
- [36] In-vitro activity of various antimicrobial peptides developed from the bactericidal domains of lysozyme and β-lactoglobulin with respect to Listeria monocytogenes, Escherichia coli O157, Salmonella spp. and Staphylococcus aureus ARCHIV FUR LEBENSMITTELHYGIENE, 2003, 54 (02): : 34 - 36
- [37] Antimicrobial activities of ceftazidime-avibactam, ceftolozane-tazobactam, and other agents against Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa isolated from intensive care units in Taiwan: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan in 2016 INFECTION AND DRUG RESISTANCE, 2019, 12 : 545 - 552
- [39] Evaluation of in vitro activity of ceftolozane/tazobactam and comparators against recent clinical bacterial isolates, and genomics of Pseudomonas aeruginosa, Klebsiella pneumoniae and Escherichia coli isolates that demonstrated resistance to ceftolozane/tazobactam: data from Kuwait and Oman JAC-ANTIMICROBIAL RESISTANCE, 2022, 4 (02):